Related Experiment Videos
Myocardial alterations in diabetes and hypertension
S M Factor1, A Borczuk, M J Charron
1Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Diabetes Research and Clinical Practice
|July 1, 1996
Summary
Diabetic cardiomyopathy may stem from diabetes and hypertension acting together, causing heart damage. Improving microcirculation and controlling blood pressure could prevent or treat this condition.
Area of Science:
- Cardiology
- Endocrinology
- Pathophysiology
Background:
- Diabetes mellitus is characterized by hyperglycemia, increasing cardiovascular risks.
- Diabetic patients exhibit susceptibility to atherosclerosis, cardiac, and cerebral complications.
- Diabetic cardiomyopathy, distinct from coronary artery disease, presents a long-recognized but poorly understood cardiac dysfunction.
Purpose of the Study:
- To review evidence for and against a purely metabolic etiology of diabetic cardiomyopathy.
- To examine the synergistic role of diabetes and hypertension in causing cardiac structural damage and ventricular dysfunction.
- To explore the potential impact of microvascular injury and therapeutic interventions on diabetic cardiomyopathy.
Main Methods:
- Review of existing clinical and experimental evidence.
- Analysis of studies investigating the interplay between diabetes, hypertension, and cardiac structure.
- Examination of findings related to microvascular function and therapeutic agents in experimental models and clinical studies.
Main Results:
- Evidence suggests diabetes and hypertension may jointly induce cardiac structural damage, leading to ventricular dysfunction and heart failure.
- Metabolic derangements of diabetes combined with hypertension-associated vascular abnormalities may cause microvascular-induced tissue injury.
- Experimental models show potential benefits of vasodilating calcium channel blockers and ACE inhibitors in mitigating tissue pathology and mortality.
Conclusions:
- Diabetic cardiomyopathy pathogenesis is complex, potentially involving the combined effects of diabetes and hypertension.
- Microvascular injury may play a significant role in the development of diabetic cardiomyopathy.
- Therapeutic strategies targeting microcirculatory flow and hypertension control may be crucial for preventing and treating diabetic cardiomyopathy, alongside metabolic control.